Do you have relapsed or refractory multiple myeloma? Have you received at least one type of treatment? If so, you may be able to take part in a research study looking at the the safety of giving an investigational medication to patients with multiple myeloma.

Have you been diagnosed with multiple myeloma that has returned and needed to be treated again? If so, you may be able to take part in a research study looking at the safety of giving a new drug called REGN5458 (Linvoseltamab) to patients with relapsed/refractory multiple myeloma.

Do you have cancer? Are you about to start immunotherapy? You may be able to participate in a research study to help answer many questions that still exist about immunotherapy like - Who is more likely to get side effects? What treatments will help control the side effects but let patients continue their cancer treatment? What factors can affect the type of side effects patients have (type of cancer or immunotherapy? previous chemo or radiation? existing autoimmune diseases?, etc.) and more.

Have you been diagnosed with multiple myeloma? If so, you may be able to take part in a research study looking at the safety of giving a new drug called Belantamab Mafodotin to patients with multiple myeloma and normal or impaired kidney function.

Are you living with Metastatic or Advanced Cancer? Are you interested in having a personal health coach to help you set healthy lifestyle goals? Your personal health coach would prescribe cardio and strength training exercises, help you monitor symptoms, and navigate you to supportive care. If you have cancer and are receiving care at UNC Cancer Center, you may be able to participate.

Do you have multiple myeloma? Have you had a stem cell transplant? If so, you may be able to take part in a research study looking at the effectiveness of giving a drug called daratumumab, along with lenalidomide, after a stem cell transplant to patients with multiple myeloma.

Have you been diagnosed with multiple myeloma or high-risk smoldering multiple myeloma? If so, you may be able to take part in a research study looking at how drugs used to treat multiple myeloma work.

Have you been diagnosed with Relapsed/Refractory Multiple Myeloma? You may be able to take part in a gene transfer research study that uses your own modified immune cells to see if it is effective in treating your cancer.

Have you been diagnosed with a plasma cell disorder? You may be able to join a registry to help us learn more about the effects of plasma cell disorders on different aspects of life.